Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: Li_2021_Pharmaceutics_13_

Reference

Title: Activation of Tenofovir Alafenamide and Sofosbuvir in the Human Lung and Its Implications in the Development of Nucleoside/Nucleotide Prodrugs for Treating SARS-CoV-2 Pulmonary Infection
Li J, Liu S, Shi J, Zhu HJ
Ref: Pharmaceutics, 13:, 2021 : PubMed

        



Related information

Gene_Locus| human-CTSA
Substrate | Tenofovir-alafenamide,


Citations formats

Li J, Liu S, Shi J, Zhu HJ (2021)
Activation of Tenofovir Alafenamide and Sofosbuvir in the Human Lung and Its Implications in the Development of Nucleoside/Nucleotide Prodrugs for Treating SARS-CoV-2 Pulmonary Infection
Pharmaceutics 13:

Li J, Liu S, Shi J, Zhu HJ (2021)
Pharmaceutics 13:



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer